Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug

    (Reuters) – Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene. U.S. District Judge Jesse Furman in Manhattan said UMB Bank was never properly appointed trustee for shareholders owning…

    Read More

    AT&T sells stake in DirecTV to TPG for $7.6 billion

    (Reuters) -AT&T said on Monday it would sell its entire 70% stake in satellite TV provider DirecTV to private equity firm TPG for $7.6 billion, exiting a business marked by declining distributions for the telecom operator. AT&T, which acquired DirecTV in 2015, signed a joint-venture agreement with TPG in 2021, in which the private equity…

    Read More

      China says US missile deployment in Philippines undermines peace

      SHANGHAI (Reuters) – Chinese Foreign Minister Wang Yi said the U.S. deployment of intermediate-range missiles in the Philippines “undermines regional peace and stability”, the foreign ministry said on Sunday. Speaking to South Korean Foreign Minister Cho Tae-yul in New York on Saturday, Wang also called for avoiding “war or chaos on the Korean Peninsula”, the…

      Read More

      Thyssenkrupp steel head prepares staff for ‘tough’ cuts

      FRANKFURT (Reuters) – Thyssenkrupp’s 27,000 steel workers must brace for deep cuts, the new head of the conglomerate’s steel division told a German newspaper, setting the stage for significant layoffs. “Tough cuts are necessary. We have to become more profitable,” Dennis Grimm, spokesperson for Thyssenkrupp Steel Europe’s (TKSE) executive board, told Westdeutsche Allgemeine Zeitung (WAZ)…

      Read More